Cyclerion Therapeuticsinc Stock Forecast

Buy candidate since Jun 12, 2026

The Cyclerion TherapeuticsInc. stock price gained 1.25% on the last trading day (Friday, 12th Jun 2026), rising from $3.21 to $3.25. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.14% from a day low at $3.11 to a day high of $3.27. The price has been going up and down for this period, and there has been a 3.17% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 17 thousand more shares were traded than the day before. In total, 39 thousand shares were bought and sold for approximately $126.73 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.39 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 18.71% during the next 3 months and, with a 90% probability hold a price between $2.84 and $8.66 at the end of this 3-month period.

CYCN Signals & Forecast

The Cyclerion TherapeuticsInc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $3.09 and $3.12. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Cyclerion TherapeuticsInc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 01, 2026, and so far it has fallen -49.06%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Cyclerion TherapeuticsInc. stock

Cyclerion TherapeuticsInc. finds support from accumulated volume at $3.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.160 (5.14%) between high and low. For the last week, the stock has had daily average volatility of 5.05%.

Our recommended stop-loss: $3.06 (-5.90%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 50 days ago.)

Trading Expectations (CYCN) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Cyclerion TherapeuticsInc. to open at $3.21, and during the day (based on 14 day Average True Range), to move between $3.16 and $3.34, which gives a possible trading interval of +/-$0.178 (+/-5.64%) up or down from last closing price. If Cyclerion TherapeuticsInc. takes out the full calculated possible swing range there will be an estimated 5.64% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.26 (0.31%) than the support at $3.16 (2.77%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cyclerion TherapeuticsInc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Cyclerion TherapeuticsInc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.482 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $3.21 ( 1.23%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk